Jubilant Pharmova Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹2,290.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.89 per cent from ₹2,122.50 crore. This corresponds to a year-on-year *(YoY) growth of 18.73 per cent.
Operating Profit
Operating Profit stands at ₹325.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 30.40 per cent from ₹249.70 crore. This corresponds to a year-on-year *(YoY) decline of 4.80 per cent.
PBDT
PBDT stands at ₹292.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 36.76 per cent from ₹214.10 crore. This corresponds to a year-on-year *(YoY) decline of 2.79 per cent.
Profit Before Tax
Profit Before Tax stands at ₹176.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 88.44 per cent from ₹93.40 crore. This corresponds to a year-on-year *(YoY) decline of 14.56 per cent.
Net Profit
Net Profit stands at ₹119.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 113.80 per cent from ₹55.80 crore. This represents a 21.15 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Jubilant Pharmova Ltd News
Jubilant Pharmova Ltd Earnings
- YOY
- QOQ
Jubilant Pharmova Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Jubilant Pharmova Ltd Research Reports
Jubilant Pharmova Ltd Financial Reports
Jubilant Pharmova Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Jubilant Pharmo | -0.64% | -2.45% | 1.68% | 4.54% | 3.47% | -16.09% |
| Natco Pharma | -0.15% | -1.17% | 0.55% | -15.53% | 13.57% | -3.70% |
| Cohance Life | -0.27% | -3.11% | -5.51% | -9.10% | 12.74% | -57.97% |
| Alembic Pharma | 0.75% | 0.93% | 4.43% | 7.83% | 7.45% | -18.89% |
| Alivus Life | -2.23% | -2.48% | -1.03% | 10.29% | 17.40% | 9.10% |
| Concord Biotech | -0.31% | -2.47% | -0.48% | 10.98% | 5.17% | -31.60% |
| Corona Remedies | -1.87% | 0.98% | 4.71% | 22.11% | 40.32% | 43.52% |
Company Info
Company Information
Chairman (Non-Executive) : Shyam S Bhartia
Co-Chairman : Hari S Bhartia
Independent Director : Vivek Mehra
Independent Director : SUSHIL KUMAR ROONGTA
Managing Director : Priyavrat Bhartia
Joint Managing Director : Arjun Shanker Bhartia
Independent Director : Arun Seth
Independent Director : Shirish Gundopant Belapure
Whole-time Director : Ramakrishnan Arul
Independent Director : Harsh Mahajan
Independent Director : Shivpriya Nanda
Whole Time Director : Arvind Chokhany
Company Sec. & Compli. Officer : Naresh Kapoor.